News
Study supports genetic testing for all breast cancer patients age 65 and younger
- Author:
- Neil Osterweil
Expanding existing genetic testing criteria to all patients age 65 and younger would improve detection of breast...
News

Second transplant a good salvage option for children with ALL, AML, or MDS
- Author:
- Neil Osterweil
Patients who had a second hematopoietic stem cell transplant after relapse had sixfold better overall survival...
News

Younger children can safely visit HSCT recipients (sometimes)
- Author:
- Neil Osterweil
Children under 12 are welcome – with suitable precautions – to visit patients at some transplant centers, but personae non grata at others.
News

Stored CD34 cells for multiple myeloma patients largely unused
- Author:
- Neil Osterweil
ORLANDO – Only 3 of 146 eligible patients actually received a salvage autologous transplant with cells collected...
News

No reduction in oral mucositis with folinic acid post transplant
- Author:
- Neil Osterweil
ORLANDO – Folinic acid, a.k.a. leucovorin, offered no benefit for reducing methotrexate-induced oral mucositis in patients receiving GVHD...
News
Safer CAR uses modified NK cells for advanced CLL, NHL
- Author:
- Neil Osterweil
Allogeneic CAR-NK cells can be delivered in adoptive transfer without the serious cytokine release syndrome and...
News
Adrenal-permissive genotype linked to poor prognosis in prostate cancer
- Author:
- Neil Osterweil
Men with an adrenal-permissive allele of the gene HSD3B1 are at high risk for worse outcomes from advanced prostate cancer.
News
Survival for older AML patients better with HSCT from unrelated donors
- Author:
- Neil Osterweil
“Our findings lend support to our hypothesis that a young [matched unrelated donor] should be the donor of choice when available,” reported the...
News

Global project reveals cancer’s genomic playbook
- Author:
- Neil Osterweil
The Pan-Cancer Analysis of Whole Genomes, an international collaboration, reveals the complexity of oncogenesis.
News
Lenvatinib/pembrolizumab has good activity in advanced RCC, other solid tumors
- Author:
- Neil Osterweil
Two-thirds of patients with advanced renal cell carcinoma had a clinical response to the TKI/immune checkpoint inhibitor combination.
News
High-dose chemo offers survival benefit only for highest-risk breast cancer
- Author:
- Neil Osterweil
Women with 10 or more involved axilliary nodes or triple-negative breast cancer had a 20-year overall survival benefit from high-dose chemotherapy...
News

Echoes of SARS mark 2019 novel coronavirus outbreak
- Author:
- Neil Osterweil
One-third of patients hospitalized for 2019 novel coronavirus infection required ICU admission, and six of the 41 (15%) died.
News
Adding cannabinoids to opioids doesn’t improve cancer pain control
- Author:
- Neil Osterweil
A systematic review and meta-analysis found no advantage of adjuvant cannabinoids for control of advanced cancer pain.
News

Promising early efficacy of venetoclax/navitoclax in r/r acute lymphoblastic leukemia
- Author:
- Neil Osterweil
ORLANDO – Combining the BCL-2 inhibitor venetoclax with low-dose navitoclax produced good response rates in heavily pretreated patients with B-...
News

REGN1979 shows good activity in pretreated aggressive B-NHL
- Author:
- Neil Osterweil
The bispecific anti-CD20/CD3 antibody induced complete responses in some heavily pretreated patients,...